Repositorio Dspace

Listar por autor "Halfon, Mario Javier"

Listar por autor "Halfon, Mario Javier"

Ordenar por:Orden:Resultados:

  • Correale, Jorge; Halfon, Mario Javier; Jack, Dominic; Rubstein, Adrián; Villa, Andrés (Elsevier, 2021-09-14)
    With the recent approval of cladribine tablets, siponimod and ozanimod, there has been a renewed interest into the extent to which these current generation disease-modifying therapies (DMTs) are able to cross into the ...
  • Silva, Berenice Anabel; Ysrraelit, María Célica; Zanga, Gisela; Segamarchi, María Constanza; Cragnolini, Carolina; Galleguillos, Lorna; Halfon, Mario Javier; Miguez, Jimena; Parada Marcilla, Marcela; Pereyra, Adriana; Silva, Emanuel; Vrech, Carlos; D'Eramo, Mariana; Negrotto, Laura (Elsevier, 2025-01-14)
    The use of additional cladribine tablets treatment courses is becoming an option in patients with multiple sclerosis (MS) showing disease activity after treatment initiation. Despite the availability over the past year of ...
  • Cristiano, Edgardo; Alonso, Ricardo; Alvez Pinheiro, Amelia; Bacile, Elizabeth A.; Balbuena Aguirre, María Eugenia; Ballario, Carlos; Barboza, Andrés G.; Bestoso, Santiago; Burgos, Marcelo; Cáceres, Fernando; Carnero Contentti, Edgar; Carrá, Adriana; Crespo, Ernesto; Curbelo, María Celeste; Deri, Norma; Fernandez, Jorge; Fernandez Liguori, Nora; Fiol, Marcela Paula; Gaitán, María Inés; Garcea, Orlando; Giunta, Diego Hernán; Halfon, Mario Javier; Hryb, Javier Pablo; Jacobo, Miguel; Kohler, Eduardo; Linares, Ramiro; Luetic, Geraldine G.; Martínez, Alejandra Diana; Míguez, Jimena S.; Nofal, Pedro G.; Patrucco, Liliana; Piedrabuena, Raúl; Rojas, Juan Ignacio; Rotta Escalante, Roberto; Saladino, María Laura; Silva, Berenice Anabel; Sinay, Vladimiro; Steinberg, Judith; Tarulla, Adriana; Vétere, Santiago A.; Villa, Andrés; Vrech, Carlos; Ysrraelit, María Célica; Correale, Jorge (Elsevier, 2018-02-15)
    One of the biggest challenges in multiple sclerosis (MS) is the definition of treatment response/failure in order to optimize treatment decisions in affected patients. The objective of this consensus was to review how ...
  • Liguori, Nora Fernández; Alonso, Ricardo; Pinheiro, Amelia Alves; Balbuena Aguirre, María Eugenia; Barboza, Andrés G.; Bestoso, Santiago; Burgos, Marcos; Cáceres, Fernando; Carnero Contentti, Edgar; Carrá, Adriana; Cristiano, Edgardo; Curbelo, María Celeste; Deri, Norma; Fiol, Marcela Paula; Gaitán, María Inés; Garcea, Orlando; Halfon, Mario Javier; Hryb, Javier Pablo; Jacobo, Miguel; José, Gustavo; Knorre, Eduardo; López, Pablo Adrián; Luetic, Geraldine G.; Mainella, Carolina; Martínez, Alejandra Diana; Miguez, Jimena; Nofal, Pedro G.; Pagani Cassará, Fátima; Parada Marcilla, Marcela; Piedrabuena, Raúl; Pita, Cecilia; Quarracino, Cecilia; Rojas, Juan Ignacio; Silva, Berenice Anabel; Sinay, Vladimiro; Steinberg, Judith; Tarulla, Adriana; Tavolini, Darío; Tkachuk, Verónica A.; Tizio, Santiago; Villa, Andrés; Vrech, Carlos; Ysrraelit, María Célica; Patrucco, Liliana (Elsevier, 2020-08)
    Background: Multiple sclerosis (MS) is the most common chronic immune-mediated neurological disorder in young adults, more frequently found in women than in men. Therefore, pregnancy-related issues have become an object ...
  • Cristiano, Edgardo; Rojas, Juan Ignacio; Alonso, Ricardo; Alvez Pinheiro, Amelia; Bacile, Elizabeth A.; Balbuena Aguirre, María Eugenia; Barboza, Andrés G.; Bestoso, Santiago; Burgos, Marcos; Cáceres, Fernando; Carnero Contentti, Edgar; Curbelo, María Celeste; Deri, Norma; Fernandez Liguori, Nora; Gaitán, María Inés; Garcea, Orlando; Giunta, Diego Hernán; Halfon, Mario Javier; Hryb, Javier Pablo; Jacobo, Miguel; Kohler, Eduardo; Luetic, Geraldine G.; Maglio, Ignacio; Martínez, Alejandra Diana; Míguez, Jimena S.; Nofal, Pedro G.; Patrucco, Liliana; Piedrabuena, Raúl; Rotta Escalante, Roberto; Saladino, María Laura; Silva, Berenice Anabel; Sinay, Vladimiro; Tkachuk, Verónica A.; Villa, Andrés; Vrech, Carlos; Ysrraelit, María Célica; Correale, Jorge (Elsevier, 2020-02-15)
    Introduction During the last 20 years, multiple sclerosis (MS) disease has seen major changes with new diagnostic criteria, a better identification of disease phenotypes, individualization of disease prognosis and the ...
  • Barboza, Andrés G.; Carnero Contentti, Edgar; Curbelo, María Celeste; Halfon, Mario Javier; Rojas, Juan Ignacio; Silva, Berenice Anabel; Sinay, Vladimiro; Tizio, Santiago; Ysrraelit, María Célica; Alonso, Ricardo (Springer, 2021-01-25)
    Background: Technological advances and greater availability of magnetic resonance imaging have prompted an increment on incidental and unexpected findings within the central nervous system. The concept of radiologically ...
  • Ysrraelit, María Célica; Caride, Alejandro; Sinay, Vladimiro; Rivera Kindel, Mario; Halfon, Mario Javier; Patrucco, Liliana; Piedrabuena, Raúl; Diaz Aragunde, Vanina Eleonor (Associacao Arquivos De Neuro-Psiquitria Dr Oswaldo Lange, 2021-05-01)
    Background: The real-world effectiveness of natalizumab in people with relapsing multiple sclerosis (PwRMS) in Argentina and Chile has not been reported. Objective: To evaluate the effectiveness of natalizumab treatment ...
  • Barboza, Andrés G.; Gaitán, María Inés; Alonso, Ricardo; Ysrraelit, María Célica; Luetic, Geraldine G.; Liwacki, Susana; Patrucco, Liliana; Halfon, Mario Javier; Burgos, Marcos; Mainella, Carolina; Piedrabuena, Raúl; Recchia, Luciano; Steinberg, Judith; Tkachuk, Verónica A.; Zanga, Gisela; Carrá, Adriana; Chertcoff, Aníbal; Fernández Liguori, Nora; Lázaro, Luciana; Menichini, María Laura (Elsevier, 2022-02-09)
    Background: There has been an increase in the number of reports of multiple sclerosis (MS) rebound activity (RA), which is usually defined as a severe disease reactivation after natalizumab or fingolimod withdrawal that ...